EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A New GlyT2 Variant Associated with Hyperekplexia

Jorge Sarmiento-Jiménez iD, Raquel Felipe, Enrique Núñez, Alejandro Ferrando-Muñoz, Cristina Benito-Muñoz iD, Federico Gago iD, Jesús Vázquez iD, Emilio Camafeita iD, Emma Clement iD, Brian Wilson iD, Beatriz López-Corcuera iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146753 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jorge Sarmiento-Jiménez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biología Molecular, Instituto de Biología Molecular (IUBM), Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investig…. Hauptthemen laut MEDLINE: Glycine Plasma Membrane Transport Proteins, Hyperekplexia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación (MCIN) MCIN/AEI/10.13039/501100011033, Fundación Ramón Areces, Fundación Ramón Areces to the CBM Severo Ochoa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperekplexia (OMIM 149400), a sensorimotor syndrome of perinatal clinical relevance, causes newborns to display an energic startle reflex in response to certain trivial stimuli. This condition can be lethal due to apnea episodes. The disease is caused by a blockade of glycinergic neurotransmission. Glycinergic interneurons preserve their identity by the activity of the surface glycine transporter GlyT2, which supplies glycine to presynaptic terminals to maintain glycine content in synaptic vesicles. Loss-of-function mutations in the GlyT2 gene (SLC6A5) cause a presynaptic form of human hyperekplexia. Here, we describe a new GlyT2 variant found in an infantile patient diagnosed with hyperekplexia. A missense mutation in the open reading frame of the GlyT2 gene inherited in homozygosity caused the substitution G449E in a residue highly conserved across the phylogenetic scale. The sequences of the glycine receptor genes GLRA1 and GLRB did not show abnormalities. We expressed the recombinant GlyT2 variant in heterologous cells and analyzed its pathogenic mechanism. The transporter was totally inactive, behaving as a bona fide loss-of-function mutant. Furthermore, the mutation promoted the abnormal insertion of the protein into the membrane, leading to its large incorporation into lipid rafts. However, there was no apparent alteration of wild-type trafficking upon mutant coexpression, as the mutant was prematurely degraded from the endoplasmic reticulum. Rescue with chemical chaperones was not possible for this mutant. Proteomics demonstrated that the expression of the mutant induced the unfolded protein response and interfered with raft-dependent processes. Therefore, the new variant causes a loss of function regarding GlyT2 activity but a gain of function as a cell proteostasis disturber.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycine Plasma Membrane Transport ProteinsHyperekplexiaHumansInfantEndoplasmic ReticulumHEK293 CellsMembrane MicrodomainsMutation, MissenseReceptors, Glycine

Stichwörter der Autor:innen

GlyT2 variantUPRglycine transporthyperekplexialipid raftproteome

Substanzen

Glycine Plasma Membrane Transport ProteinsReceptors, GlycineSLC6A5 protein, human

Autor:innen und Institutionen

  • Departamento de Biología Molecular, Instituto de Biología Molecular (IUBM), Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, 28049 Madrid, Spai…
  • Department of Biomedical Sciences, University of Alcalá (UAH), Alcalá de Henares, 28805 Madrid, Spain.
  • Centro Nacional de Investigaciones Cardiovasculares (ISCIII), 28029 Madrid, Spain.
  • CIBER de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.
  • North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Trust, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK.

ORCID-Profile: Jorge Sarmiento-Jiménez, Cristina Benito-Muñoz, Federico Gago, Jesús Vázquez, Emilio Camafeita, Emma Clement, Brian Wilson, Beatriz López-Corcuera

Förderung

  • Ministerio de Ciencia e Innovación (MCIN) MCIN/AEI/10.13039/501100011033
  • Fundación Ramón Areces
  • Fundación Ramón Areces to the CBM Severo Ochoa
  • NextGenerationEU/PRTR
  • ERDF A way of making Europe
  • European Union NextGenerationEU/PRTR
  • MCIN/AEI/10.13039/501100011033
  • Comunidad de Madrid

Zitieren

APA

Sarmiento-Jiménez, J., Felipe, R., Núñez, E., Ferrando-Muñoz, A., Benito-Muñoz, C., Gago, F., Vázquez, J., Camafeita, E., Clement, E., Wilson, B., & López-Corcuera, B. (2025). A New GlyT2 Variant Associated with Hyperekplexia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146753

Vancouver

Sarmiento-Jiménez J, Felipe R, Núñez E, Ferrando-Muñoz A, Benito-Muñoz C, Gago F, et al. A New GlyT2 Variant Associated with Hyperekplexia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146753

BibTeX
@article{SarmientoJimnez2025,
  author = {Sarmiento-Jiménez, Jorge and Felipe, Raquel and Núñez, Enrique and Ferrando-Muñoz, Alejandro and Benito-Muñoz, Cristina and Gago, Federico and Vázquez, Jesús and Camafeita, Emilio and Clement, Emma and Wilson, Brian and López-Corcuera, Beatriz},
  title = {A New GlyT2 Variant Associated with Hyperekplexia},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146753}
}
Kostenlos starten →